Mind Cure Health's Senior Product and Marketing Manager, Sacha Hebbert, talks about the company's recent launch of its product sales division.
Similar Posts
Interview with Doug Drysdale, CEO, Cybin Inc
Doug talks about the company’s mission to revolutionize mental healthcare, how Cybin is delivering powerful and effective therapies, and why being the first psychedelic-based company to list on the New York Stock Exchange was a natural fit. Cybin can be found on the NYSE under the ticker symbol $CYBN.
A Misnomer in Mushrooms: The Jedi Mind Fuck Strain
Come discover the world of the enigmatic Jedi Mind Fuck strain. Is it a significantly more potent strain or is it all hearsay?
Daniel Carcillo On Psychedelics For TBI, Wesana Partnering With MAPS & Mike Tyson Collaboration
During our time at Wonderland Miami, $PSYC CEO, David Flores,…
Ketamine Therapy for High Performance Athletes with Dr. Sam Zand and Derek Du Chesne
In this episode, we discuss how ketamine therapy can help high-performance professional athletes and corporate executives.
Wesana Health’s Dr. ABID NAZEER – The Parallels Between Brain Injury & Addiction (WESA)
Wesana Health’s Dr. ABID NAZEER – The Parallels Between Brain…
Interview With James Hallifax
In this episode of the Psychedelic Spotlight podcast, we feature James Hallifax, Co-Founder of The Psychedelic Investor.